- Report
- June 2024
- 232 Pages
Global
From €4770EUR$4,995USD£3,989GBP
- Report
- September 2024
Global
From €4583EUR$4,799USD£3,833GBP
- Report
- May 2024
- 454 Pages
Global
From €4727EUR$4,950USD£3,953GBP
- Report
- March 2025
- 89 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- March 2025
- 198 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- March 2025
- 180 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- October 2024
- 181 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- March 2025
- 89 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- March 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- January 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- September 2024
- 100 Pages
Global
From €4536EUR$4,750USD£3,794GBP
- Report
- September 2024
- 200 Pages
Global
From €4726EUR$4,949USD£3,953GBP
- Report
- May 2024
- 250 Pages
Global
From €4770EUR$4,995USD£3,989GBP
- Report
- July 2024
- 143 Pages
Global
From €4059EUR$4,250USD£3,394GBP
- Report
- February 2023
- 185 Pages
Global
From €1814EUR$1,899USD£1,517GBP
- Report
- January 2023
- 231 Pages
Global
From €4583EUR$4,799USD£3,833GBP
- Report
- October 2022
- 115 Pages
Global
From €3104EUR$3,250USD£2,596GBP
- Report
- September 2018
- 111 Pages
Global
From €4727EUR$4,950USD£3,953GBP
- Report
- October 2022
- 320 Pages
Global
From €3581EUR$3,750USD£2,995GBP
- Report
- April 2023
- 109 Pages
Global
From €5682EUR$5,950USD£4,752GBP

Bioinks are specialized biomaterials designed for use in 3D bioprinting applications, which involve the creation of three-dimensional structures, such as tissues and organs, from cells and biomaterials. These inks must possess proper rheological properties to allow precise deposition, maintain cell viability, and facilitate tissue maturation post-printing. The development of bioinks is an interdisciplinary field that intersects material science, biology, and engineering. Bioinks can be derived from natural sources, like collagen, gelatin, and alginate, or can be synthetically produced, such as polyethylene glycol (PEG) based hydrogels. They are tailored to replicate the extracellular matrix, providing a supportive environment for cell proliferation and differentiation. Recent advances have aimed at improving the functionality and complexity of bioinks to enable the fabrication of structures that more closely mimic the natural tissue characteristics, through the incorporation of growth factors, signaling molecules and incorporating different cell types.
In the market of bioinks, a variety of companies have emerged, providing products and services for the growing field of tissue engineering and regenerative medicine. Some notable companies specializing in the development and supply of bioinks include CELLINK, Allevi, Regenovo, Bio3D Technologies, 3D Systems, and Organovo. These companies continue to innovate by offering a range of bioink formulations and bioprinting solutions to cater to the research needs and commercial applications in the bioprinting sector. Show Less Read more